Found: 2
Select item for more details and to access through your institution.
Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 2, p. 261, doi. 10.1177/13524585231223069
- By:
- Publication type:
- Article
Factors affecting the topography of nitrous oxide‐induced neurological complications.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 7, p. 1, doi. 10.1111/ene.16291
- By:
- Publication type:
- Article